Nationwide Walk Series Kicks Off July 20 in Pittsburgh
CHICAGO, June 27, 2024 /PRNewswire/ — The Pulmonary Fibrosis Foundation (PFF) today announced its 2024 PFF Walk series, a nationwide effort to raise funds and awareness for pulmonary fibrosis (PF) and interstitial lung disease (ILD). More than 250,000 Americans are living with PF and ILD, progressive diseases that cause inflammation, scarring, or both, that damage the lung’s ability to absorb oxygen from the air.
The PFF Walk will kick off on July 20 in Pittsburgh and will continue through October in cities across the U.S. —
“By walking together in solidarity, our community finds strength and inspiration to eliminate PF and ILD. Each step offers incredible support and hope for a brighter future, while raising vital funds to fuel our mission,” said Scott Staszak, Interim President and CEO of the PFF. Since its inception in 2017, the PFF Walk has raised more than $5 million.
The PFF Walk unites people living with PF, caregivers and families, lung transplant recipients, and all community members. Each Walk features one- and two-mile course options. Participants are encouraged to go at their own pace. The events will also include a variety of activities and entertainment, including music, food and family fun.
In addition to the site-specific walks in six cities, National Walk Day offers a virtual opportunity for everyone, everywhere to participate. Those impacted by PF and ILD are invited to choose a walk location in their community and gather family and friends to join.
Registration for the PFF Walk is free. Walkers who raise $100 or more will receive a commemorative PFF Walk t-shirt. To register or for more information, visit PFFWalk.org. Special thanks to the PFF Walk National Sponsors – Accredo, Amgen, Boehringer Ingelheim, CSL Behring, CVS Specialty Pharmacy, Pliant Therapeutics, Inc., Tvardi Therapeutics and United Therapeutics.
About the Pulmonary Fibrosis Foundation
The mission of the Pulmonary Fibrosis Foundation is to accelerate the development of new treatments and ultimately a cure for pulmonary fibrosis. Until this goal is achieved, the PFF is committed to advancing improved care of patients with PF and providing unequaled support and education resources for patients, caregivers, family members, and health care providers. The PFF has a four-star rating from Charity Navigator and is an accredited charity by the Better Business Bureau (BBB) Wise Giving Alliance. The Foundation has met all of the requirements of the National Health Council Standards of Excellence Certification Program® and has earned the Guidestar Platinum Seal of Transparency. For more information, visit pulmonaryfibrosis.org or call 844.TalkPFF (844.825.5733).
Contact: Dorothy Coyle
773-332-6201
SOURCE The Pulmonary Fibrosis Foundation
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…
CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…
MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…